Advertisement

Topics

Merck: Anleger skeptisch

10:53 EDT 16 Apr 2019 | FinanzNachrichten

Kulmbach (www.aktiencheck.de) - Merck-Aktienanalyse von Marion Schlegel, Redakteurin des Online-Anlegermagazins "Der Aktionär": Marion Schlegel von "Der Aktionär" nimmt in einer aktuellen Aktienana...

Original Article: Merck: Anleger skeptisch

NEXT ARTICLE

More From BioPortfolio on "Merck: Anleger skeptisch"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...